CheckMyRecalls

VITRUVIAS THERAPEUTICS INC recalls Thyroid Tablets

Published
23 Sept 2026
Units affected
1955 bottles
Agency
FDA
Country
United States

The hazard

Superpotent Drug

Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.

Brand / company
VITRUVIAS THERAPEUTICS INC
Codes / lots
Lot # 504950, Exp Date: 09/30/2026.
Distribution
US Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 23 Sept 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.